Allon Therapeutics Inc. (NPCUF)

0.0001 0.0000 (0.00%) At close: 02:46PM EDT

Allon Therapeutics Inc.

1168 Hamilton Street
Suite 506
Vancouver, BC V6B 2S2
Canada
604-736-0634
https://www.allontherapeutics.com

Sector(s): 
Industry: 
Full Time Employees: 8

Description

Allon Therapeutics Inc., a clinical-stage biotechnology company, focuses on developing and marketing central nervous system therapies. Its preclinical drug candidate comprises AL-309 for the treatment of peripheral neuropathy. The company was formerly known as Neuro Discovery Inc. and changed its name to Allon Therapeutics Inc. in September 2004. Allon Therapeutics Inc. was incorporated in 1994 and is headquartered in Vancouver, Canada.

Corporate Governance

Allon Therapeutics Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.